It’s time to start preparing for the 2026–2027 flu season! CPP members once again have multiple opportunities to receive significant…
Discount
Rising vaccine costs continue to challenge independent practices across the country. These increases can strain budgets, impact profitability and even…
We’re excited to share that Merck’s new monoclonal antibody, Enflonsia™, is now part of the CPP portfolio. This addition reflects the…
CPP Members! There will be a new Pfizer contract in place effective July 1, 2025 that offers CPP members an…
Motivate to Vaccinate – CPP members, join us on June 24 at 12PM ET (9AM PT) for a live webinar…
May is Hepatitis Awareness Month, and Dynavax is spearheading efforts to improve education about hepatitis B and the benefits of…
The COVID-19 pandemic reshaped public attitudes toward vaccines, highlighting their vital role in protecting individual and community health. With this…
The United States is witnessing a troubling rise in measles cases, with a significant outbreak in Texas reaching 90 confirmed…
The CDC published updated expanded recommendations from the Advisory Committee on Immunization Practices (ACIP) for pneumococcal conjugate vaccines (PCV) among…
There was quite a bit of discussion at the October ACIP meeting about the exciting advancements in preventing invasive pneumococcal…